Impax Laboratories Inc

Type: Company
Name: Impax Laboratories Inc
Nationality: United States
First reported Oct 28 2014 - Updated Oct 28 2014 - 2 reports

IPXL Shareholder Alert: Do You Own Stock in IPXL Educational Services?

Related Stocks IPXL - Impax LaboratoriesSym Last Chg Pct Volume IPXL28.15+0.01+0.04%27,946 SAN FRANCISCO , Oct. 28, 2014 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is actively investigating alleged misconduct by Impax Laboratories Inc.'s (NASDAQ: ... [Published Barchart - Oct 28 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 3 reports

Impax Announces Departure of Carole Ben-Maimon, M.D., President of Global Pharmaceuticals

at 16:05 PM EDT Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that Carole Ben-Maimon, M.D., president of Global Pharmaceuticals, the ...Related Stocks ... [Published Fat Pitch Financials - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 2 reports

JMP Securities Initiates Impax Laboratories With Outperform

Analysts at JMP Securities initiated coverage on Impax Laboratories (NASDAQ: IPXL) with a Outperform rating. The target price for ... ... [Published Atlanta Journal And Constitution - Oct 22 2014]
First reported Oct 09 2014 - Updated Oct 10 2014 - 7 reports

Impax Laboratories Inc. (IPXL) in Focus: Stock Rises 11.8%

Impax Laboratories Inc. (IPXL) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the ... [Published Yahoo! Finance - Oct 10 2014]
First reported Oct 09 2014 - Updated Oct 10 2014 - 13 reports

Impax to acquire two pharma companies

Singapore: Impax Laboratories announced that it has agreed to buy private pharmaceutical companies Tower Holdings Inc and Lineage Therapeutics Inc for $700 million in cash.The acquisition will also include operating subsidiaries CorePharma LLC and Amedra ... [Published Bio Spectrum Asia - Oct 10 2014]
First reported Oct 09 2014 - Updated Oct 10 2014 - 2 reports

RoundTable parts with 2005 investment CodePharma through $700m Tower Holdings sale

RoundTable Healthcare Partners has agreed the $700m sale of Tower Holdings to tech-based pharma company Impax Laboratories. ... [Published AltAssets.net - Oct 10 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 8 reports

Impax Laboratories Inc (NASDAQ:IPXL) Long-Term Investor Alert: Lawsuit Against Directors Filed

San Diego, CA -- ( ReleaseWire ) -- 10/08/2014 -- The Shareholders Foundation announces that an investor, who currently holds shares of Impax Laboratories Inc ( NASDAQ:IPXL ), filed a lawsuit against certain director of Impax Laboratories over alleged ... [Published SBWire - Oct 08 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 3 reports

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces Update to the Shareholder Lawsuit Against Impax Laboratories, Inc.

Glancy Binkow & Goldberg LLP filed a shareholder class action lawsuit on August 13, 2014, in the United States District Court for the Northern District of California on behalf of…Click to Continue » ... [Published Fort Mills Times - Oct 07 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 2 reports

Impax Laboratories : to Announce Results for Third Quarter 2014 on November 4

HAYWARD, Calif., Oct. 7, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the Company will release its third quarter 2014 financial results on Tuesday, November 4, 2014, prior to the open of the U.S. financial markets. ... [Published 4 Traders - Oct 07 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 2 reports

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Impax Laboratories, Inc.

BENSALEM, Pa.--(BUSINESS WIRE)--Contact Law Offices of Howard G. Smith if you purchased Impax Laboratories, Inc. securities between May 20, 2013 and July 28, 2014. ... [Published Business Wire Professional Services News - Oct 06 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 2 reports

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Impax Laboratories, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of October 13, 2014

NEW YORK--(EON: Enhanced Online News)--Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Impax Laboratories ... [Published EON Business - Oct 03 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 2 reports

Two Week Reminder: Hagens Berman Reminds Impax Laboratories, Inc. Investors of the Oct. 14, 2014 Lead Plaintiff Class-Action Deadline

) - Hagens Berman Sobol Shapiro LLP, a top-tier investor-rights law firm, reminds investors of the October 14, 2014, lead plaintiff deadline in the securities fraud class action against Impax Laboratories, Inc. ( NASDAQ: IPXL ) ("Impax" or "the Company"). ... [Published Street Sweeper - Sep 30 2014]

Quotes

"I am grateful for the relationships and support I have enjoyed over the past three years at Impax," said Dr. Ben-Maimon. "Impax is a great company, and I am confident that with its committed employees and under Fred's leadership, the company will continue to grow and successfully execute its growth strategy."
Fred Wilkinson, president and CEO of Impax, said, "The acquisition also adds a branded and generic pipeline that includes a number of near-term opportunities. In addition, Impax will gain an established campus in New Jersey focused on R&D, manufacturing, packaging and supply chain management. Further, this accretive transaction will move Impax to a more efficient capital structure, while also preserving our ability to pursue additional external strategic growth opportunities."
Christopher Worrell, CEO Tower Holdings, Amedra and Lineage, said: "We are pleased with the progress we have made across our companies with an emphasis on the successful implementation of a Quality Improvement Program, which resulted in recent product approvals from the U S FoodFood and Drug Administration. Both Impax and the companies have a proven record of developing high value specialty products, and we look forward to being a critical contributor to the future growth strategy and value creation for Impax."
...of the steepest declines Friday after the CEO of Arizona chipmaker Microchip Technology warned about impending doom for semiconductor companies. "Microchip often sees the turn of the industry ahead of others in the semiconductor industry. ... We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future" Steve Sanghi wrote in a warning about his company's disappointing quarterly revenues, explaining that his company's revenue recognition standards would...

More Content

All (190) | News (100) | Reports (0) | Blogs (59) | Audio/Video (0) | Fact Sheets (0) | Press Releases (31)
sort by: Date | Relevance
Biggest Movers in Healthcare Stocks Now – HTWR ... [Published InvestorPlace.com - 14 hours ago]
The Medicines Co.'s Angiomax Gets Favorable Cou... [Published Nasdaq - Oct 28 2014]
The Medicines Co.'s Angiomax Gets Favorable Cou... [Published Zacks.com - Oct 28 2014]
IPXL Shareholder Alert: Do You Own Stock in IPX... [Published Barchart - Oct 28 2014]
IPXL Shareholder Alert: Do You Own Stock in IPX... [Published PR Newswire: Financial Services - Oct 28 2014]
Biggest Movers in Healthcare Stocks Now – NKTR ... [Published InvestorPlace.com - Oct 27 2014]
Pfizer Walks From Remoxy; Is This The End Or Ar... [Published Yahoo! Finance - Oct 27 2014]
FTSE slips as pharmaceutical and telecoms share... [Published Guardian.co.uk - Oct 24 2014]
Impax Announces Departure of Carole Ben-Maimon,... [Published Fat Pitch Financials - Oct 22 2014]
Impax Announces Departure of Carole Ben-Maimon,... [Published Wall Street Select - Oct 22 2014]
Impax Announces Departure of Carole Ben-Maimon,... [Published PR Newswire: Business Technology - Oct 22 2014]
Hottest Healthcare Stocks Now – ACHC BSX CBST GSK [Published InvestorPlace.com - Oct 22 2014]
Stock Investors Bid Up Shares of Impax Laborato... [Published Individual.com - Oct 22 2014]
JMP Securities Initiates Impax Laboratories Wit... [Published Atlanta Journal And Constitution - Oct 22 2014]
NASDAQ:IPXL Long-Term Investor Alert: Lawsuit a... [Published Empowered News - Oct 22 2014]
JMP Securities Initiates Impax Laboratories Wit... [Published Benzinga.com - Oct 22 2014]
Hottest Healthcare Stocks Now – CMN ISRG STE TRNX [Published InvestorPlace.com - Oct 21 2014]
Hottest Healthcare Stocks Now – BLUE ANAC QGEN STJ [Published InvestorPlace.com - Oct 18 2014]
Analyst Rating In Review: Impax Laboratories Bi... [Published Individual.com - Oct 17 2014]
Impax Laboratories Up 1.3% Since WallachBeth Up... [Published Individual.com - Oct 17 2014]
Impax to acquire Tower Holdings and Lineage The... [Published Center Watch - Oct 16 2014]
IMPAX LABORATORIES : Lieff Cabraser Reminds Imp... [Published 4 Traders - Oct 16 2014]
New therapies to treat niche populations will d... [Published Pharma Letter - Oct 15 2014]
Endo and Impax Face Another Pay-for-Delay Lawsu... [Published FDA News - Oct 15 2014]
Biggest Movers in Healthcare Stocks Now – IPXL ... [Published InvestorPlace.com - Oct 15 2014]
Impax Labs acquires Tower Holdings for $700 mil... [Published Drug Store News - Oct 14 2014]
Impax Laboratories Receives Consensus Recommend... [Published Mideast Time - Oct 14 2014]
Middle-Market Deal Making Surges in First Three... [Published FOXBusiness.com - Oct 13 2014]
SolarCity offers homeowners loans to buy solar ... [Published FOX Business - Video - Oct 13 2014]
Can The Uptrend Continue for Impax Laboratories... [Published Yahoo! Finance - Oct 13 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
IPXL Shareholder Alert: Do You Own Stock in IPX... [Published PR Newswire: Financial Services - Oct 28 2014]
SAN FRANCISCO, Oct. 28, 2014 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is actively investigating alleged misconduct by Impax Laboratories Inc.'s (NASDAQ: IPXL) top executives, including claims that Impax's officers and directors breached their ...
Impax Announces Departure of Carole Ben-Maimon,... [Published PR Newswire: Business Technology - Oct 22 2014]
HAYWARD, Calif., Oct. 22, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that Carole Ben-Maimon, M.D., president of Global Pharmaceuticals, the Company's generic pharmaceutical division, has resigned for personal and family ...
SolarCity offers homeowners loans to buy solar ... [Published FOX Business - Video - Oct 13 2014]
FBN’s Lauren Simonetti on middle-market deal activity, Impax Laboratories’ latest acquisitions and SolarCity’s new loan program. ...
Impax agrees to buy Tower Holdings and Lineage ... [Published PBR - News - Oct 13 2014]
Impax Laboratories has announced the execution of a definitive agreement under which Impax will acquire Tower Holdings, including operating subsidiaries CorePharma and Amedra Pharmaceuticals, and Lineage Therapeutics (together, the "Companies") for $700m ...
The Morning Leverage: In It for the Long(er) Haul [Published WSJ.com: Private Equity Beat - Oct 10 2014]
Mike Lucas for Dow Jones From this morning’s LBO Wire: RoundTable Healthcare Partners is selling Tower Holdings Inc. , which includes operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, as well as Lineage Therapeutics Inc. to pharmaceutical ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
CORRECTING and REPLACING -- SHAREHOLDER ALERT: ... [Published GlobeNewswire: Acquisitions News - Oct 10 2014]
RoundTable Healthcare Partners Announces Sale o... [Published Financial Services - Oct 09 2014]
EQUITY ALERT: The Rosen Law Firm Reminds Impax ... [Published GlobeNewswire: Acquisitions News - Oct 02 2014]
Faruqi & Faruqi, LLP Encourages Investors Who S... [Published Financial Services - Oct 01 2014]
UPCOMING DEADLINE: Levi & Korsinsky, LLP Remind... [Published Financial Services - Sep 29 2014]
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.